About: Calvary Mater Newcastle Hospital

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Calvary Mater Newcastle Hospital Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

healthcare organization in Waratah, Australia

Attributes	Values
rdf:type	Item
description	griya sakit (jv) rumah sakik (min) rumoh sakét (ace) rumah sakit di Australia (id) Krankenhaus in Australien (de) مستشفى في نيوساوث ويلز، أستراليا (ar) healthcare organization in Waratah, Australia (en)
rdfs:label	Calvary Mater Newcastle Hospital (en)
skos:prefLabel	Calvary Mater Newcastle Hospital (en)
name	Calvary Mater Newcastle Hospital (en)
ROR ID	wds:Q30254214-E63F7E1C-2342-4AA2-9BFB-6522F8839216
ROR ID	04kbz1397
instance of	wds:Q30254214-2EDBB8DD-1344-4243-83FA-5240633325CC wds:Q30254214-A0E0E298-57F4-43D7-96D8-D0252FEE542C
instance of	hospital medical organization
country	wds:Q30254214-8FAC8513-EE36-4B6D-B640-E330BE66FF8F
country	Australia
HAL structure ID	wds:Q30254214-B99C6BAE-277B-47CA-879A-ABE2CD051BFB
HAL structure ID	544578
Open Funder Registry funder ID	wds:Q30254214-51EEB7D4-09D4-4B63-88E2-DFC8118F02B4
Ringgold ID	wds:Q30254214-B14B8E78-4516-4386-BDA9-9526613920C7
Open Funder Registry funder ID	100013027
Ringgold ID	8249
inception	wds:Q30254214-F734490B-0443-4A94-B1F2-43B68369D16D
inception	1885-01-01 00:00:00Z (xsd:dateTime)
located in the adm...erritorial entity	wds:Q30254214-32FF58AD-E417-48E9-B564-4CB31CECB136
ISNI	wds:Q30254214-04B5259C-CF4E-4A6B-8663-A2325B7E64F2
VIAF ID	wds:Q30254214-4110B454-B578-492F-8B3C-65F0037C4C40
Library of Congress authority ID	wds:Q30254214-3B1D6234-2F58-4955-8299-E239E8BD1BA5
coordinate location	wds:Q30254214-10A7A52D-EF20-43A4-8902-4A6D940987DF
WorldCat Identities ID (superseded)	wds:Q30254214-36EA3EA8-12F4-4F51-9192-58CE4F6A70E1
official website	wds:Q30254214-D360D0D8-B6DE-4511-8562-A0E5FD913E36
VIAF ID	http://viaf.org/viaf/127176332
Library of Congress authority ID	http://id.loc.gov/authorities/names/n2010180566
located in the adm...erritorial entity	New South Wales
ISNI	0000000087629215
VIAF ID	127176332
Library of Congress authority ID	n2010180566
coordinate location	POINT(151.720748 -32.898842)
WorldCat Identities ID (superseded)	lccn-n2010180566
official website	https://www.calvarycare.org.au/public-hospital-mater-newcastle/
GRID ID	wds:Q30254214-05884EAD-F7F8-4E60-A498-F76B7F6D1B6E
GRID ID	grid.413265.7
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30254214
is research site of	221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer. A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD) A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects Assessment of New Radiation Oncology Technologies and Treatments A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing) Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia Merkel Positron Emission Tomography (PET) Protocol Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy Combination Immunotherapy in Rare Cancers Under InvesTigation Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer A Study of Cobimetinib Plus Paclitaxel, Cobimetinib Plus Atezolizumab Plus Paclitaxel, or Cobimetinib Plus Atezolizumab Plus Nab-Paclitaxel as Initial Treatment for Participants With Triple-Negative Breast Cancer That Has Spread Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural Mesothelioma Radiotherapy or Imiquimod in Complex Lentigo Maligna EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer Pembrolizumab in Combination With Epacadostat or Placebo in Cisplatin-ineligible Urothelial Carcinoma (KEYNOTE-672/ECHO-307) Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) Radiotherapy - Adjuvant Versus Early Salvage RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Radiation Therapy or Temozolomide in Treating Patients With Gliomas Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer NLA101 in Adults Receiving High Dose Chemotherapy for AML Tucatinib Together With Pembrolizumab and Trastuzumab Imgatuzumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL) A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) A Study Evaluating the Safety and Efficacy of Venetoclax (GDC-0199) Plus Bendamustine + Rituximab (BR) in Comparison With BR or Venetoclax Plus Rituximab in Participants With Relapsed and Refractory Follicular Non-Hodgkin's Lymphoma (fNHL) A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer Chemoradiotherapy in Patients With Localised Lung Cancer Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma Chemotherapy and Radiotherapy for Osteolymphoma

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software